Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Daniel J. Stein MD
Director, Associate Professor
Department of Medicine
Division of Gastroenterology

OFFICE ADDRESS:
Milwaukee, WI 53226

EDUCATION:
08/1989 - 05/1994 Diploma, Cudahy High School, Cudahy, WI
08/1994 - 05/1998 B.S. - Biology, Marquette University, Milwaukee, WI
08/1999 - 05/2003 M.D., Creighton University School of Medicine, Omaha, NE

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
07/01/2003 - 06/30/2006 Internal Medicine Internship and Residency, Internal Medicine, University of Arizona, Tucson, AZ
07/01/2007 - 06/30/2010 Gastroenterology and Hepatology Fellowship, Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI
11/01/2009 - 12/01/2009 Visiting Inflammatory Bowel Disease Fellow, Gastroenterology, University of Chicago, Chicago, IL

FACULTY APPOINTMENTS:
07/01/2010 - 06/30/2016 Assistant Professor, Internal Medicine, Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI
07/01/2010 - Present Gastroenterology and Hepatology, Children's Hospital of Wisconsin, Milwaukee, WI
07/01/2011 - Present Gastroenterology and Hepatology, Clement J. Zablocki Veterans Affairs Hospital, Milwaukee, WI
07/01/2016 - Present Associate Professor, Medicine, Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI

ADMINISTRATIVE APPOINTMENTS:
07/01/2006 - 06/30/2007 Chief Resident - Internal Medicine, Internal Medicine, University of Arizona Internal Medicine, Tucson, AZ
08/2013 - Present Access Champion for the Division of Gastroenterology and Hepatology, Internal Medicine, Gastroenterology and Hepatology, Froedtert and the Medical College of Wisconsin, Milwaukee, WI
06/01/2015 - Present Medical Director of the Inflammatory Bowel Disease Program at Froedtert and the Medical College of Wisconsin, Internal Medicine, Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI
04/2023 - 02/2027 Department of Medicine Vice Chair for Education, Medical College of Wisconsin, Milwaukee, WI

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
06/01/2012 - Present Director, M2 GI and Nutrition Subunit, Discovery Curriculum, Medical College of Wisconsin, Milwaukee, WI
07/01/2016 - Present Fellowship Program Director, Department of Medicine, Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI
01/2022 - Present Block Director, Gastrointestinal Integrated Science Block, Curriculum Innovation, School of Medicine, Medical College of Wisconsin, Milwaukee, WI

HOSPITAL STAFF PRIVILEGES:
06/03/2010 - Present Children's Hospital of WI, Milwaukee, WI
07/01/2010 - Present Froedtert Hospital, Milwaukee, WI
09/07/2010 - Present Froedtert Surgery Center, Milwaukee, WI
07/01/2011 - Present Zablocki VA Medical Center, Milwaukee, WI

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
Internal Medicine
08/2006
12/2016
Gastroenterology
10/2010
12/2021
   
Certificates
Issued By Issue DateExpiration
BLS
American Heart Association
03/2014
03/2020
ACLS
American Heart Association
07/2014
09/2023
    

Licensure
Number Issue DateExpiration
AZ Medicine and Surgery
35649
06/14/2006
02/05/2008
WI Medicine and Surgery
50499
06/12/2007
None
    

AWARDS AND HONORS:
1998 - Present Phi Beta Kappa , Marquette University
1998 - Present Magna Cum Laude, Marquette University
05/2000 - 08/2000 Crohn’s and Colitis Foundation of America: 2000 Solvay Pharmaceuticals Student Research Fellowship “Selective Leukocyte Binding by Microvascular Endothelial Cells in Crohn’s Disease”, Medical College of Wisconsin
10/2005 - Present Selected Attendee to 3rd Annual Choosing a Career in Academic Gastroenterology Conference, Medical College of Wisconsin – Division of Gastroenterology and Hepatology
2005 - 2007 Associate Representative, American College of Physicians
2006 - 2007 Chief Resident Internal Medicine, University of Arizona Internal Medicine Residency Program
2008 - Present Attendee, IBD Mentoring Program for GI Fellows
2010 - Present Fellowship2Leadership, Salix Fellows Program, DDW
07/01/2013 - 06/30/2014 MCW Outstanding Medical Student Teacher Pin, Medical College of Wisconsin
01/30/2018 - 01/31/2018 MCW Outstanding Medical Student Teacher Pin, Medical College of Wisconsin
11/06/2020 Catalyst for Mission Advancement Award, Crohn's & Colitis Foundation
01/15/2021 High-Performing Reviewer for Inflammatory Bowel Diseases, Inflammatory Bowel Diseases journal
2023 2023 Department of Medicine James M. Cerletty Award for Excellence, Medical College of Wisconsin

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
07/01/2007 - Present American College of Gastroenterology (Member)
07/01/2007 - Present Crohn's and Colitis Foundation of America (Member)
07/01/2007 - 07/01/2012 American Society for Gastrointestinal Endoscopists (Member)
07/01/2007 - Present American Gastroenterology Association
08/01/2011 - Present Milwaukee GI Society (Member)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Journal Review
2015 - Present Inflammatory Bowel Disease
2017 - Present Gastroenterology and Hepatology Review
2018 - Present Clinical Gastroenterology and Hepatology
2022 - Present BMJ Open
Digestive Disease Sciences (DDS)

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
06/01/2010 - Present Board Member, Crohn's and Colitis Medical Advisory Board Milwaukee, Crohn's and Colitis Foundation of America, Milwaukee Chapter
03/2012 - Present Director, Annual Inflammatory Bowel Disease Update, Medical College of Wisconsin Inflammatory Bowel Disease Annual Update
07/01/2015 - Present Board Member, Wisconsin Chapter Board, Crohn's and Colitis Foundation of America
01/01/2016 - Present Director, Crohn's and Colitis MCW and CHW Patient and Family Education Program, Medical College of Wisconsin
01/01/2016 - 01/01/2018 Secretary, Milwaukee Gastroenterological Society, Milwaukee Gastroenterological Society
01/13/2016 - Present Board Member, Crohn's and Colitis Foundation, Wisconsin Advisory Board, Crohn's and Colitis Foundation
07/01/2018 - Present Counsel Member, Marquette Alumni Association Mentor Program Counsel, Marquette Alumni Association
01/2019 - 12/2020 President, Milwaukee Gastroenterological Society, Milwaukee GI Society

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
02/2024 - Present Fellow, American Gastroenterological Association
2024 - 2027 Member, Crohn's & Colitis Foundation's National Scientific Advisory Committee (NSAC)

INTERNATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
03/15/2023 - Present Member, Education Committee - GI Fellowship Program, University of Rwanda

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Non-Peer Review
Title:
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis (UC)
Source:
Legacy
Role:
PI
Dates:
04/2013 - Present
  
Title:
An Open-Label Extension and Safety Monitoring Study of Moderate to Severe Ulcerative Colitis Patients Previously Enrolled in Etrolizumab Phase II/III Studies
Source:
GA28951 (Hoffmann-La Roche)
Role:
PI
Dates:
09/15/2014 - 08/16/2025
Direct Funds:
$0
  
Title:
The Association Between Body Composition and Response to Therapy in Inflammatory Bowel Disease Patients.
Source:
Medical College of Wisconsin, Digestive Disease Center
Role:
Sub-Investigator
Dates:
2016 - Present
  
Title:
Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD).
Source:
Crohn’s and Colitis Foundation
Role:
Sub-Investigator
Dates:
2017 - Present
  
Title:
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433
Source:
AbbVie
Role:
Principal Investigator
Dates:
03/21/2018 - Present
  
Title:
A phase III, randomized, double blind, parallel group, placebo controlled, international, multicentre study to assess efficacy and safety of Cx601, adult allogeneic expanded adipose-derived stem cells (eASC), for the treatment of complex perianal fistula(s) in patients with Crohn’s disease over a period of 24 weeks and a follow-up period up to 52 weeks (ADMIRE-CD II)
Source:
Takeda
Role:
Sub-Investigator
PI:
Poonam Beniwal-Patel, MD
Dates:
2019 - Present
  
Title:
The PROP-RD Study: A Prospective Registry for the Study of Outcomes and Predictors in Pouchitis and Pouch-Related Disorders (PROP-RD)
Source:
University of North Carolina Chapel Hill
Role:
Sub-Investigator
Dates:
2019 - Present
  
Title:
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Assess the Efficacy and Safety of Etrasimod in Subjects with Moderately to Severely Active Ulcerative Colitis. (APD334-301)
Source:
Arena
Role:
Sub-Investigator
Dates:
2019 - Present
  
Title:
A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction Therapy in Subjects with Moderately to Severely Active Crohn’s Disease (APD334-202)
Source:
Arena Pharmaceuticals
Role:
Sub-Investigator
Dates:
2020 - Present
  
Title:
A multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of apraglutide in adult subjects with short bowel syndrome and intestinal failure (TA799-007)
Source:
Takeda
Role:
Sub-Investigator
PI:
Amir Patel, MD
Dates:
2020 - Present
  
Title:
Proactive infliximab optimization using a pharmacokinetic dashboard versus standard of care in patients with Crohn’s disease: The OPTIMIZE Trial
Source:
Beth Israel Deaconess Medical Center/Helmsley Charitable Trust
Role:
Sub-Investigator
Dates:
2021 - Present
  
Title:
A Phase 2b Randomized, Double-blind, Active- and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to Severely Active Ulcerative Colitis.
Source:
Janssen
Role:
PI
Dates:
2022 - Present
  
Title:
Study to Asses the Genotype of Subjects with Diagnosis of Ulcerative Colitis or Crohns Disease (The PRELUDE Study)
Source:
Prometheus Biosciences
Role:
Sub-Investigator
Dates:
2022 - Present
  
Title:
A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Crohn's Disease.
Source:
Janssen
Role:
PI
Dates:
2022 - Present
  
Title:
A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration
Source:
M14-115
Role:
PI
  
Title:
A Phase 3, Open-label Study to Determine the Long-term Safety and Efficacy of Vedolizumab (MLN0002) in Patients with Ulcerative Colitis and Crohn’s Disease
Source:
Millennium
Role:
PI
  
Prior
Non-Peer Review
Title:
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects with Moderately to Severely Active Crohn's Disease (CD)
Source:
AbbVie (prior sponsor, Abbott)
Role:
PI
Dates:
09/2007 - 12/2015
  
Title:
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated with Certolizumab Pegol (Cimzia®) for Crohn's Disease
Source:
SECURE
Role:
PI
Dates:
01/2009 - 08/2020
  
Title:
A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease
Source:
RedHill Biopharma Limited
Role:
PI
Dates:
09/2013 - 08/2019
  
Title:
PHASE III, DOUBLE BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF ETROLIZUMAB DURING INDUCTION AND MAINTENANCE IN PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS WHO ARE REFRACTORY TO OR INTOLERANT OF TNF INHIBITORS
Source:
GA 28950 (Hoffman-LaRoche)
Role:
PI
Dates:
05/21/2014 - 04/16/2020
  
Title:
Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy (Maintenance of Remission) and Safety of Etrolizumab Compared With Placebo in Patients With Moderate to Severe Active Ulcerative Colitis Who Are Naive to TNF Inhibitors
Source:
GA29102 (Hoffmann-La Roche)
Role:
PI
Dates:
08/12/2014 - 04/06/2020
  
Title:
A Multicenter, Open-Label Study to Evaluate the Long Term Effacacy, Safety, and Tolerability of Repeated Administration of Adalimumab in Subjects with Crohn's Disease
Source:
M14-347
Role:
PI
Dates:
12/2014 - 09/2016
  
Title:
Study of FS-0809, Oral FMT Capsules, for Yreatment of Recruitment Closttridium difficle infection
Source:
PR#032016-1
Role:
PI
Dates:
07/2016 - 03/2018
  
Title:
A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis
Source:
M14-033 (AbbVie)
Role:
PI
Dates:
09/26/2016 - 02/28/2022
  
Title:
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis
Source:
AbbVie
Role:
Principal Investigator
Dates:
05/2017 - 03/2020
  
Title:
A Randomized, Double-blind, Placebo-Controlled, Multi-Center Phase 1b Study to Evaluate the Safety, Efficacy and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment
Source:
Assembly Biosciences
Dates:
06/24/2019 - 01/20/2021
  
Title:
Presence of SARS-CoV-2 in stool samples of COVID-19 cases: Potential for Transmission Via Stool Shedding.
Source:
Advancing a Healthier Wisconsin Endowment
Role:
Sub-Investigator
Dates:
2020 - 2022
  
Title:
Correlation Between Vedolizumab Serum Levels, Anti-Vedolizumab Antibodies, and Disease Activity in Subjects with IBD.
Source:
Prometheus Labs
Role:
Sub-Investigator
  
Title:
A Phase 3 Multicenter, Long-Term Extension Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) in Subjects with Ulcerative Colitis
Source:
AbbVie
Role:
Principal Investigator
  
Title:
The Effect of Timing of Anti-TNF alpha Therapy on Surgical Outcomes in Inflammatory Bowel Disease Patients.
Source:
MCWFH
  

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
Probiotics and Inflammatory Bowel Disease, Crohn’s and Colitis Foundation of America – Milwaukee Chapter Monthly Meeting, Milwaukee, WI, 05/10/2010
New Therapies in IBD, Crohn’s and Colitis Foundation of America – Milwaukee Chapter Monthly Meeting, Milwaukee, WI, 06/07/2010
Inflammatory Bowel Disease and The Endoscopy Lab, Froedtert Lutheran Memorial Hospital Gastroenterology Nursing Education Program, Milwaukee, WI, 08/03/2010
Update on the IBD Center, Digestive Disease Center Board Meeting, Milwaukee, WI, 10/2010
Lunch and Learn “The Celiac Iceberg”, Plank Road Clinic, Milwaukee, WI, 03/03/2011
Lunch and Learn “The Celiac Iceberg”, Sunnyslope Clinic, Milwaukee, WI, 03/16/2011
Lunch and Learn “The Celiac Iceberg”, Lincoln Avenue Clinic, Milwaukee, WI, 04/13/2011
Autonomic Dysfunction and the Gut, Milwaukee Autonomic Support Group, Milwaukee, WI, 02/2013 - Present
Optimizing Therapy for Crohn's Disease, Pharmacy Department Meeting, Froedtert Hospital, 02/10/2014
IBD and the Endoscopy Lab, Building a Better Team - Share Your Knowledge, Froedtert Hospital, 02/12/2014
Modern Disease Management in IBD, Allergy and Immunology Grand Rounds, Children's Hospital of Wisconsin, 03/07/2014
GI motility disorders, Symptoms Unit session, Discovery Classroom - Milwaukee, WI, 04/09/2014
Update on the Inflammatory Bowel Disease Program, Digestive Disease Board Meeting 6/1/2015, Milwaukee, WI, 06/01/2015
Approach to Upper GI Bleeding in the CVICU, CVICU Lecture Series, Milwaukee, WI, 06/09/2015
Diarrhea, 2016 Symptoms Unit of the M-2 Discovery Curriculum, Discovery Classroom, 04/12/2016
Integrating Clinical and Basic Sciences Into a Single Educational Experience, MCW Innovations in Medical Education Conference, Milwaukee, WI, 04/28/2016
GI Bleeds in the CVICU Population: Prevention and Treatment, CVICU Lecture series, Milwaukee, WI, 06/21/2016
IBD, 2016 Digestive Disease Week Meeting Review, Milwaukee, WI, 10/01/2016
The Gut Microbiome and You, AHW Endowment’s Conversations with Scientists Fall series, Milwaukee, WI, 10/26/2016
Diarrhea, 2017 Symptoms Unit of the M-2 Discovery Curriculum, Milwaukee, WI, 04/11/2017
Crohn's and Colitis: Looking Like Crap from the Inside Out, Milwaukee IBD Education Conference (Crohn's & Colitis Foundation), Zootopia Conference Center - Milwaukee, WI, 12/02/2017
Introduction to Crohn’s Disease and Ulcerative Colitis, Spring Community Education Class, Community Conference Center, 03/06/2018
C diff/Enteric Infections, Academic Half Day Lecture-Interns, Medical College of Wisconsin, 11/21/2018
Inflammatory Bowel Disease, DDW Review, Brookfield, WI, 09/14/2019
Medical School Curriculum Exploration Retreat, Crowne Plaza - Milwaukee, WI, 10/02/2019
Gluten Sensitivity Spectrum, GIM Noon Conference, Zablocki VA - Milwaukee, WI, 10/30/2019
Celiac Disease and Gluten Sensitivity Disorders: Is Gluten Really Evil?, Gastroenterology Grand Rounds, Froedtert Hospital, Milwaukee, WI, 11/15/2019
Celiac Spruce, Academic Half Day Lecture-Residents, Milwaukee, WI, 12/04/2019
Navigating Healthcare in a New World, Lunch and Learn Webinar for the Crohn's and Colitis Foundation - WI Chapter, 06/01/2020
Celiac and Gluten Sensitivity, Fellowship Board Review, Medical College of Wisconsin, 03/03/2021
Celiac Disease and Gluten Sensitivity Disorders: Is Gluten Really Evil?, GIM Seminar Series, Medical College of Wisconsin, 05/21/2021
MyIBD Learning Live and Ondemand, live stream, 10/02/2021
Difficult Cases, stopping medications, combo therapy, and other situations. IBD Panel Discussion, Crohn’s and Colitis Foundation Conference: A Patient and Provider Point of Care Conference, Wauwatosa, WI, 05/07/2022
Daniel Stein, MD, Celiac Disease, The Department of Medicine Grand Rounds, Medical College of Wisconsin, Milwaukee, WI, 01/19/2024
 
Regional
Optimizing Therapy in Crohn's Disease, Medical College of Wisconsin Inflammatory Bowel Disease Update, Medical College of Wisconsin, 03/31/2012
Optimizing Therapy for Inflammatory Bowel Disease, Grand Rounds St. Agnes Hospital, Fond Du Lac, Wisconsin, 05/31/2012
Celiac Disease and Gluten Sensitivity, Medical College of Wisconsin Internal Medicine Grand Rounds, Milwaukee, WI, 04/05/2013
Therapeutic Drug Monitoring In Inflammatory Bowel Disease Patients, Medical College of Wisconsin IBD Update, Milwaukee WI, 04/13/2013
Disease and Drug Monitoring in Inflammatory Bowel Disease, MCW IBD Annual Update, Crowne Plaza Hotel - Wauwatosa, WI, 03/15/2014
Approach to Chronic Diarrhea, State of the Gut, Brookfield, WI, 09/19/2014
Modern Approach to Managing Inflammatory Bowel Disease, WSGNA 2014 Fall Conference, Brookfield, WI, 11/07/2014
Update on Crohn’s Disease Therapy, MCW IBD Annual Update, Milwaukee, WI, 03/14/2015
Modern Disease Management In Inflammatory Bowel Disease, CCFA Wisconsin Patient Education Program, Milwaukee, WI, 04/27/2015
Approach to Patient Care and Research at the Inflammatory Bowel Disease Program at the Medical College of Wisconsin, Digestive Disease Committee Pro-Am Golf Tournament Fundraiser, Milwaukee, WI, 08/24/2015
Digestive Disease Week Review - Inflammatory Bowel Disease, Digestive Disease Week Review, Milwaukee, WI, 09/17/2015
Clostridium Difficile Update, "State of the Gut" An Update on Gastrointestinal Disorders, Sheraton Brookfield Hotel, 09/18/2015
Inflammatory Bowel Disease Patient Question and Answers, Crohn's and Colitis Foundation of America Wisconsin Chapter Meeting, Milwaukee, WI, 10/03/2015
Inflammatory Bowel Disease: Taking Control of Your Disease, Froedtert Community Health Education Series, Milwaukee, WI, 11/03/2015
Non-Celiac Gluten Intolerance, 46th Annual Winter Refresher Course for Family Medicine, Pewaukee, WI, 02/04/2016
Inflammatory Bowel Disease: Taking Control of Your Disease., Froedtert Community Health Education Series, Community Conference Center, 02/11/2016
Stopping and De-escalating therapy in IBD, 2016 MCW IBD Update, Milwaukee WI, 03/12/2016
Complimentary and Alternative Therapies in IBD, MCW Patient and Family Crohn's and Colitis Program, Milwaukee WI, 03/12/2016
Crohn's and Colitis: Taking Control of Your Disease, Carroll College and CCFA Patient Education Program, Waukesha, WI, 03/22/2016
Clostridium difficile update: what's new for an old problem?, CME Committee for the Medical Staff of St. Agnes Hospital, St Agnes Hospital/Fond du Lac Regional Clinic, 04/07/2016
Crohn’s and Colitis, Fall Community Education Class, Community Conference Center - Milwaukee, WI, 09/15/2016
Gluten Sensitivity Disorders, Wisconsin Academy of Physician Assistant (WAPA) 2016 Fall Conference, Osthoff Resort in Elkhart Lake, WI, 10/13/2016
IBD, Wisconsin Patient Education Program, Zoofari Conference Center - Milwaukee, WI, 12/03/2016
Modern approach to treating inflammatory bowel disease, MCW Department of Dermatology Academic Half Day Conference, Froedtert Specialty Clinics Building, 01/25/2017
Alternatives to colonoscopy, Winter Refresher Course, Milwaukee Marriott West - Waukesha, WI, 02/03/2017
UGI bleeding, Pulmonary and Critical Care Grand Rounds, Froedtert Hospital - Milwaukee, WI, 03/03/2017
Judge for posters, The Department of Medicine Research Retreat, Harley-Davidson Museum - Milwaukee, WI, 03/10/2017
IBD IMITATORS, 2017 MCW IBD Update, Embassy Suites - Brookfield, WI, 03/11/2017
Complementary & Alternative Medicine in Inflammatory Bowel Disease, Crohn's and Colitis Patient and Family Education Program, Brookfield, WI, 03/11/2017
Inflammatory Bowel Disease, Wisconsin Academy of Physician Assistants (WAPA) Spring Conference, Osthoff Resort in Elkhart Lake, 10/12/2017
Judge for posters, Department of Medicine 4th Annual Research Retreat, Harley-Davidson Museum - Milwaukee, WI, 03/09/2018
Stopping Meds in IBD, Crohn’s and Colitis Foundation Conference: A Patient and Provider Point of Care Conference, 05/12/2018
Celiac Disease, "State of the Gut” 2018, Brookfield, WI, 09/28/2018
What Is The Best Way To Deal With Anxiety and Depression in IBD Patients?, Crohn’s and Colitis Foundation Conference, Milwaukee, WI, 05/12/2019
IN/WI Patient Education program, virtual, 12/05/2020
Celiac Disease and Gluten Sensitivity Disorders, Medicine Grand Rounds, Zablocki Veterans Affairs Medical Center, 08/27/2021
IN/WI Patient Education program, 12/05/2021
 
National
Gluten Sensitivity Disorders, 50th Annual Medical College of Wisconsin Clinical Conference, Clearwater Beach, FL, 02/29/2016 - 03/04/2016
Inflammatory Bowel Disease for the Non-GI Provider, 50th Annual Medical College of Wisconsin Clinical Conference, Clearwater Beach, FL, 02/29/2016 - 03/04/2016
New Agents for IBD: Biosimilars for all?, Digestive Disease Week (DDW), Clinical Symposium, Virtual, 05/23/2021
 
International
Daniel Stein, MD, Inflammatory Bowel Disease and Complications, Rwanda GI Resident/Fellowship Program Collaboration Visit, King Faisal Hospital, Kigali, Rwanda, 03/14/2023
Daniel Stein, MD, Celiac Disease, Rwanda GI Resident/Fellowship Program Collaboration Visit, King Faisal Hospital, Kigali, Rwanda, 03/15/2023
Daniel Stein, MD, C. Difficile infection / Enteric Infection, Rwanda GI Resident/Fellowship Program Collaboration Visit, King Faisal Hospital, Kigali, Rwanda, 03/15/2023
 

PEER REVIEWED WORKSHOPS/PRESENTATIONS:
National
Stein,D et. al., Inflammatory Bowel Disease Patients on Immunosuppressive Therapy in Endoscopic Remission Have a High Rate of Post Inflammatory Bowel Disease-Irritable Bowel Syndrome which is Associated with a Diminished Quality of Life., Digestive Disease Week 2012, San Diego, CA, 05/19/2012 - 05/22/2012
Modiri, A, Stein, D, et al, Inflammatory Bowel Disease Patients With Solid Organ Transplants Who Require Anti-TNF Therapy Are Not at Increased Risk of Serious Infections., Digestive Disease Week 2015, Washington D.C., 05/16/2015 - 05/19/2015
 

COMMITTEE SERVICE:
Medical College of Wisconsin
2011 - Present Interviewer, Incoming Gastroenterology Fellowship Program Applicants, Medical College of Wisconsin
2011 - Present Interviewer, Internal Medicine Residency Program Applicants, Medical College of Wisconsin
06/01/2012 - Present Co-Director M2 GI and Nutrition Subunit, Discovery Curriculum, Medical College of Wisconsin
06/01/2012 - Present Member, M2 Unit Directors Committee, Medical College of Wisconsin
06/01/2012 - Present Member, Directors of Medical Student Education Committee
12/01/2013 - Present Member, Department of Medicine Access Champion Committee
06/01/2014 - 2019 Member, Division of Gastroenterology and Hepatology Faculty Recruitment Committee
01/01/2015 - 06/30/2015 Fellow Improvement Sub-committee, Gastroenterology
05/01/2015 - Present Member, GI Daily Improvement Committee, Gastroenterology, Medicine
06/01/2015 - 07/30/2015 Member, Bonus Distribution Guideline Development Task Force, Medicine, Medical College of Wisconsin
07/01/2015 - Present IBD Research Committee, Gastroenterology and Hepatology
06/2016 - 03/2017 Combined Ambulatory PNT & Therapeutics Committee, Froedtert and MCW
07/25/2016 - 07/25/2017 Cardiology Chief Search Committee, Cardiovascular Medicine, Medicine
09/2016 - Present Clinical Competency Committee, Gastroenterology and Hepatology
09/2016 - 2019 Associate Vice Chair Ambulatory Ops, Medicine
11/01/2016 - 04/01/2017 Chair, Digestive Disease Committee 2017 Grant Review Committee
01/30/2017 - 2020 Nutrition Committee
08/2017 - 2019 Member, GI Optimization Meeting, Department of Medicine
09/01/2017 - 06/30/2020 Member, MCWAH Graduate Medical Education Committee (GMEC)
09/28/2017 - Present Member, Medical College of Wisconsin Affiliated Hospital’s (MCWAH) Program Review Subcommittee
02/19/2018 - 08/30/2018 Team Lead, Special Full Review, Allergy & Immunology Fellowship Program
09/13/2018 - Present Member, DOM Research Retreat Committee, Medicine
10/2018 - Present Access & Growth Workgroup, Department of Medicine
07/01/2019 - 07/01/2021 Member, Faculty Council
07/01/2020 - 06/30/2022 MCWAH Graduate Medical Education Committee (GMEC)
09/2020 - Present Curriculum Exploration Steering committee
2020 - Present Member, MCWAH’s 2020 Research and Quality Award Committee
01/2021 - 06/2021 Member, CEC ad hoc inter-campus comparability committee
 
Hospital
11/01/2014 - 03/2017 Member, Ambulatory Care Pharmacy and Therapeutics Committee
08/01/2015 - Present Member, Specialty Pharmacy/340B Advisory Group, GI, Pharmacy, Froedtert Hospital and Medical College of Wisconsin
01/20/2016 - Present Committee Member, MCP Patient Services and Operations Committee, Medical College Physicians
06/2018 - Present Social Dyad, Gastroenterology and Hepatology
09/2018 - Present No-Show/Same Day Cancellations Workgroup
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Community/Lay Public
10/26/2016 Conversations with Scientists: It’s Contagious - The World of Infectious Disease evening program
 
Medical Student Education
06/01/2010 - 06/01/2014 M3 Board Review: GI and Hepatology Review
06/01/2010 - Present M4 Inflammatory Bowel Disease Rotation Attending
07/01/2010 - Present GI Consult Rotation: Outpatient Clinic Attending
06/01/2011 - Present Ambulatory Clinics Rotation Attending
01/01/2013 - Present M1 Clinical Apprenticeship Preceptor
01/09/2014 M2 GI&N Subunit Lecture: Pathology of the Esophagus and Stomach - Case Presentation
01/16/2014 M2 GI&N Subunit Lecture: Case of Weight Loss and Diarrhea
01/21/2014 M2 GI&N Subunit Lecture Miscellaneous Disorders of the GI Tract
01/21/2014 M2 GI&N Subunit Lecture C. Difficle Colitis
01/21/2014 M2 GI&N Subunit Lecture Approach to Diarrhea
01/22/2014 M2 GI&N Subunit Lecture: Celiac Disease
01/23/2014 M2 GI&N Subunit Lecture: Introduction to Inflammatory Bowel Disease
01/23/2014 M2 GI&N Lecture: Subunit Tumors of the Large and Small Bowel - Case based discussion
03/03/2014 ACP/student networking reception. Reception aimed at increasing student interest in Internal Medicine and Medicine Sub-Specialties
04/09/2014 Symptoms M2 Subunit. Lecture: USMLE Board Review
04/09/2014 Symptoms M2 Subunit. Lecture: Two Cases of Nausea, Vomiting and Weight Loss
01/08/2015 M2 GI&N Subunit Lecture: Pathology of the Esophagus and Stomach - Case Presentation
01/15/2015 M2 GI&N Subunit Lecture: Case of Weight Loss and Diarrhea
01/20/2015 M2 GI&N Subunit Lecture: Approach to Diarrhea
01/21/2015 Lecture: Case Based Review of the M2 GI&N Subunit
01/22/2015 M2 GI&N Subunit Lecture: Introduction to Inflammatory Bowel Disease
01/22/2015 M2 GI&N Subunit Lecture: Miscellaneous Disorders of the GI Tract
01/22/2015 M2 GI&N Subunit Lecture: Tumors of the Large and Small Bowel - Case Based Discussion
01/22/2015 M2 GI&N Subunit Lecture: Celiac Disease
03/26/2015 12th Annual Student Networking Reception sponsored by MCW's student chapter of the ACP.
04/18/2015 Symptoms M2 Subunit. Lecture: Diarrhea
01/07/2016 Clinical Correlations: Upper GI Pathology
01/14/2016 GI&N M2 Subunit: Clinic Correlation: Pancreatic Case Discussion
01/20/2016 GI&N M2 Subunit: Approach to Diarrhea
01/20/2016 GI&N M2 Subunit: Gluten Sensitivity Disorders
01/20/2016 GI&N M2 Subunit: Introduction to Inflammatory Bowel Disease
01/21/2016 GI&N M2 Subunit: Clinical Correlations: Lower GI Pathology
01/26/2016 GI&N M2 Subunit: Breakfast Club Case Discussion
04/12/2016 Diarrhea session - M2 Symptoms Unit
08/31/2016 Bench to Bedside - Preceptor Session - Clinical Reasoning Exercise
09/06/2016 13th Annual Student Networking Reception sponsored by MCW's student chapter of the ACP.
01/06/2017 M2 GI-Nutrition Unit: Integrated Clinical Case Based Discussion: Peptic Ulcer Disease, Gastric Neoplasms, and Pathology
01/17/2017 M2 GI-Nutrition Unit: Mechanisms of Diarrhea
01/18/2017 M2 GI-Nutrition Unit: Celiac Disease and IBD
01/18/2017 M2 GI-Nutrition Unit: Inflammatory Bowel Disease
04/11/2017 M2 Symptoms Unit: Diarrhea
08/30/2017 Bench to Bedside course: Clinical reasoning exercise – GI pathology
01/15/2018 - 01/20/2018 Preceptor for M1 students in the Clinical Apprenticeship course
01/16/2018 GI Nutrition Unit: Mechanisms of Diarrhea
01/17/2018 M2 GI/Nutrition Unit: Celiac Disease & IBD
01/18/2018 M2 GI/Nutrition Unit: Miscellaneous Disorders
01/19/2018 M2 GI/Nutrition Unit: Integrated Review & Clinical Correlation: Intestinal Inflammatory and Neoplastic Diseases
01/07/2019 GI/Nutrition - Integrated Clinical Case Based Discussion: Pathology of the Esophagus and Stomach
01/14/2019 M2 GI and Nutrition Subunit - Clinical Case Based Discussion: Diseases of the Liver and Pancreas
01/15/2019 M2 GI/Nutrition Unit: Miscellaneous Disorders - OPEN STUDY podcast
01/17/2019 M2 GI and Nutrition Subunit-Celiac Disease & Gluten Sensitivity Disorders
01/17/2019 M2 GI/Nutrition Unit: Inflammatory Bowel Disease
01/18/2019 M2 GI and Nutrition Subunit - Mechanisms of Diarrhea
01/21/2019 M2 GI/Nutrition unit - Clinical Correlation: Intestinal Inflammatory and Neoplastic Diseases
01/24/2019 M2 GI/Nutrition - Integrated Review and Clinical Correlation
08/16/2019 - 11/11/2019 Mentorship in Medicine Meetings
08/28/2019 M2 Bench to Bedside course
01/02/2020 M2 GI/Nutrition Unit: Introduction and Expectations
01/07/2020 M2 GI/Nutrition Unit: Interactive Integrated Clinical Case Based Discussion: Pathology of the Esophagus and Stomach
01/14/2020 M2 GI/Nutrition Unit: Pancreatitis
01/16/2020 M2 GI/Nutrition Unit: Inflammatory Bowel Dz
01/16/2020 M2 GI/Nutrition Unit: Mechanisms of Diarrhea
01/17/2020 M2 GI/Nutrition Unit: Celiac Disease & Gluten Sensitivity Disorder
01/21/2020 M2 GI/Nutrition Unit: Interactive Clinical Correlation: Intestinal Inflammatory and Neoplastic Diseases
09/19/2020 M1 networking program through the Kern Institute
01/18/2021 M2 GI and Nutrition Units
01/14/2022 M2 GI and Nutrition unit - Mechanisms of Diarrhea
01/17/2022 M2 GI and Nutrition unit - Inflammatory Bowel Disease
01/17/2022 M2 GI and Nutrition unit - Celiac Disease & Gluten Sensitivity Disorders
01/20/2022 M2 GI/Nutrition Unit: Miscellaneous Disorders - OPEN STUDY podcast
 
Resident and Fellow Education
06/01/2010 - Present IBD and Clinics Rotation Attending
06/01/2010 - Present GI Fellow Board Review: IBD and Infections of the GI Tract
07/01/2010 - Present GI Consult Rotation: Outpatient Clinic Attending
07/01/2010 - Present Core Curriculum Conference: GI Fellows
07/01/2010 - Present Journal Club: GI Fellows (Recurring Meeting)
07/01/2010 - Present Quality Assurance Meeting: GI Division Recurring Meeting
07/01/2010 - Present Attending GI Inpatient Consult Service: Teach Fellows, Residents and Students on Inpatient Consult Service
07/01/2010 - Present Teach and Supervise GI Fellows Learning Endoscopy at the Milwaukee VA Hospital
07/01/2010 - Present Inflammatory Bowel Disease Inpatient Service Attending: Educate and supervise GI fellow and internal medicine residents on inpatient IBD service on a weekly basis
07/01/2010 - Present Clinical Seminar: GI Fellowship Recurring Meeting
07/01/2012 - Present Internal Medicine Noon Report Faculty
07/01/2012 - Present Attending: GI Fellow Continuity Clinic
12/2012 - Present Lecture: Management of Inflammatory Bowel Disease for the Internist
04/2013 - Present Introduction to Endoscopy for First Year Surgical Resident
12/16/2013 Lecture: Introduction to Inflammatory Bowel Disease
12/01/2014 Lecture: Introduction to Inflammatory Bowel Disease
12/10/2015 Resident Academic Halfday lecture: Advanced IBD
12/07/2016 Academic Half Day Lecture: IBD
03/06/2017 PGY 2 Lecture: Medical Mgmt of IBD
11/29/2017 Academic Half Day Lecture, Residents: C diff & Enteric Infections
09/03/2019 GI Clinical Pathology Conference (VA Zablocki)
12/04/2019 Academic Half Day Lecture-Residents (Celiac Sprue)
12/09/2020 Academic Half Day Lecture (Residents) C-Diff
05/26/2021 Academic Half Day Lecture (Interns)-Diarrhea/Constipation
11/10/2021 Academic Half Day Lecture-Residents: Small/Large Bowel Disease
 
Continuing Medical Education
09/05/2019 GI Clinical Pathology Conference (Froedtert Hospital)
11/15/2019 DOM Grand Rounds - Topic: “Celiac Disease and Gluten Sensitivity Disorders: Is Gluten Really Evil?"
01/19/2024 DOM Gastroenterology Grand Rounds:"Celiac Sprue"
 

EXTRAMURAL TEACHING:
Resident and Fellow Education
03/14/2023 - Present University of Rwanda, University Teaching Hospital of Kigali
 
Continuing Medical Education
05/04/2017 Watertown Memorial Hospital, Celiac Syndrome: The truth and facts of celiac disease
 

MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Undergraduate Students
Ann Nohl, Medical College of Wisconsin, 06/01/2011 - 07/01/2012 Research Mentor
 
Medical Students
Medical College of Wisconsin, 07/01/2012 - 05/01/2013 M4 Student Advisor
Imaan Ansari, Medical College of Wisconsin, 09/01/2013 - 06/30/2014 Research Mentor
David Ingram, Medical College of Wisconsin, 01/01/2014 - 07/01/2017 Quips Advisor/Scholarly Pathway
Alexander Chartier, Medical College of Wisconsin
 
Clinical/Research Fellows
James Kwiatt, Medical College of Wisconsin, 07/01/2009 - 06/30/2011 Research Mentor
Syed Rizvi, Medical College of Wisconsin, 06/01/2012 - 06/01/2014 Research Mentor
Mukund Venu, Medical College of Wisconsin, 07/01/2012 - 06/30/2013 Research Mentor
Amar Naik, Medical College of Wisconsin, 07/01/2012 - 12/30/2014 Research Mentor
Alexandra Modiri, Medical College of Wisconsin, 06/01/2014 - 07/01/2017 Research Mentor
Dilpesh Agrawal, MD, Medical College of Wisconsin, 06/23/2014 - Present Career Advancement
 
Residents
Sonja Bhati, Medical College of Wisconsin, 07/01/2010 - 06/30/2012 Research Mentor
Parin N. Desai, Medical College of Wisconsin, 06/01/2011 - 07/30/2012 Research Mentor
Amil Patel, Medical College of Wisconsin, 07/01/2011 - 06/30/2012 Research Mentor
Adeeti Chiplunker, Medical College of Wisconsin, 07/01/2012 - 06/30/2014 Research Mentor
Jennifer Cahill, Medical College of Wisconsin, 09/01/2014 - 07/01/2017 Research Mentor
Sonya Dave, MD, Medical College of Wisconsin, 03/2020 - Present
 
Faculty
Vikram Kanagala, Medical College of Wisconsin, 07/01/2012 - 06/30/2015 Research Mentor
Andres Yarur, MD, Medical College of Wisconsin, 07/01/2015 - Present
Amir Patel, MD, Medical College of Wisconsin, 08/03/2016 - Present Career Advancement
Poonam Beniwal-Patel, MD, Medical College of Wisconsin, 11/07/2016 - Present Career Advancement
 

EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
Undergraduate Students
Connor O'Neill, Marquette University, 09/2016 - 2017 Academic mentorship
Jacob Anderson, Marquette University, 09/01/2017 - Present Academic mentorship
 

PROGRAMMATIC DEVELOPMENTS:
Educational Programs
Fellow
07/01/2010 - Present Visiting IBD Fellow Program: Coordinate and educate visiting GI fellows interested in learning more about the management IBD by rotating through our inflammatory bowel disease program.
07/01/2010 - Present GI Fellow IBD/Clinics rotation: Instrumental in the design and development of the GI fellows IBD rotation
09/01/2014 - Present Inflammatory Bowel Disease Working Group: Director of a monthly multidisciplinary meeting focusing on the management of IBD patients
 
 
Clinical Programs
06/01/2012 - Present Fecal Microbiota Transplant Program: Developed and organized the first regulated fecal microbiota transplant program in Southeastern Wisconsin for the treatment of Clostridium difficile infections.
01/01/2013 - Present IBD New Patient Intake Program: Developed an efficient and organized program aimed at optimizing the new patient experience for the Inflammatory Bowel Disease Program
01/2013 - Present Pharmacist Integration with IBD Program: Integrated pharmacist into IBD program helping to monitor and to teach patients about their immunosuppressive medications.
02/2014 - Present Gastroenterology Nutritionist Program: Coordinated with Froedtert hospital for nutritionist support in the GI clinic to help manage our IBD, Celiac Disease, Irritable Bowel Syndrome patients.
01/04/2015 - Present Development of IBD Program ADIET Program: Comprehensive program aimed at improving patient satisfaction of all patients in the Inflammatory Bowel Disease Program
03/01/2015 - Present IBD Program Promotional Development: Work with Medical College Physicians, Froedtert Hospital and the Medical College of Wisconsin to promote the Inflammatory Bowel Disease Program
07/01/2017 - Present Gastroenterology Fellowship Continuity Clinic at Froedtert Hospital
07/01/2018 - Present Inflammatory Bowel Disease Transition Clinic
 
 

COMMUNITY SERVICE ACTIVITIES:
05/2009 - Present Crohn's and Colitis "Take Steps" Walk to raise money for IBD research. Once yearly fundraising walk - participant and fundraiser.
01/04/2011 - Present St. Jude's the Apostle Winterfest, yearly, Church festival volunteer.
06/01/2011 - 07/30/2012 Mentor Community Nurse Practitioner Anne Nohl in volunteer Research project. "Autonomic Dysfunction and Inflammatory Bowel Disease"
06/07/2015 - Present "Pie a GI" at the annual Crohn's and Colitis "Take Steps" Walk to raise money for IBD research. Volunteered to take cream pies in the face for patients who were high fundraisers.
01/21/2016 - Present Men of St. Jude's. Group focused on raising funds to benefit the students and community around St. Jude's the Apostle Church
08/01/2016 - Present Marquette University Alumni Association Mentorship Program - Mentor undergraduate student pursuing a career in the health sciences.
09/01/2016 - Present Marquette University Alumni Association Mentor Program
12/01/2016 - 03/03/2018 Wauwatosa Recreation Department basketball coach
2017 - 2018 20-YEAR Marquette University Reunion + Homecoming 2018 Planning Committee
2018 - Present Marquette University Alumni Association Mentorship Program Leadership Council
2019 - Present Crohn's & Colitis Foundation Autumn Affair
06/08/2020 Webinar Recording: Navigating Healthcare in a New World Pt. 1 Drs. Daniel Stein (Froedtert & Medical College of Wisconsin) and Abdul Elkadri (Children's Wisconsin) joined Kelly Fitzgerald, Education Manager, on June 1st to discuss tips for IBD patients to best manage their healthcare as it relates to COVID-19.
06/15/2020 Webinar Recording: Navigating Healthcare Part 2 - discussing tips for IBD patients to best manage their healthcare as it relates to COVID-19.
 

AMERICAN GASTROENTEROLOGICAL ASSOCIATION (AGA) FALL ADVOCACY DAY:
09/23/2021 Participated in AGA Fall Advocacy Day

CAREER DEVELOPMENT ACTIVITIES:
03/24/2017 - 03/26/2017 2017 Training Directors' Workshop
01/23/2018 - 01/24/2018 DYAD Leadership Development Program
02/20/2018 Knowledge Now: Identifying and Maximizing Your Teaching Style
02/22/2018 Kern Institute Grand Rounds: Utilizing Character to Rediscover Joy in the Practice of Medicine
02/26/2018 GME Program Director Retreat
02/03/2020 - Present Wellness 1/2 Day program
02/19/2020 MCWAH Graduate Medical Education Program Director (PD) Retreat
03/09/2021 - 03/31/2021 The Clinical & Translational Science Institute of Southeast Wisconsin (CTSI): Multidisciplinary Team Science Workshop Series
03/09/2022 - 03/31/2022 CTSI Multidisciplinary Team Science Workshop Series

HEALTH BLOGS:
03/07/2017 Better for Your Backside: Six Facts to Know About Colonoscopy

UNIVERSITY OF MICHIGAN DAILY IMPROVEMENT MODEL WORKSHOP:
06/08/2015 - 06/10/2015 Workshop developed by the University of Michigan College of Engineering that seeks to deepen the understanding of the Daily Improvement Model that works to improve clinical and administrative efficiency.


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Stein DJ, Ananthakrishnan AN, Issa M, Williams JB, Beaulieu DB, Zadvornova Y, Ward A, Johnson K, Knox JF, Skaros S, Binion DG. Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease. Inflamm Bowel Dis. 2010 Jul;16(7):1173-9.
2. Rafiee P, Stein DJ, Nelson VM, Otterson MF, Shaker R, Binion DG. Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC). Am J Physiol Gastrointest Liver Physiol. 2010 Feb;298(2):G167-76. PMCID: PMC2822501
3. Nguyen DM, El-Serag HB, Henderson L, Stein DJ, Bhattacharyya A, Sampliner RE. Medication usage and the risk of neoplasia in patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2009 Dec;7(12):1299-304.
4. Stein DJ, Hashem B. El-Serag, M.D., M.P.H., John Kuczynski, M.D., Jennifer R. Kramer Ph.D., M.P.H., Richard E. Sampliner, M.D. The Association of Barrett's Esophagus and Body Mass Index. Alimentary Pharmacology & Therapeutics. 2005 Nov 15;22(10):1005-10.
5. Fons ME, Stein DJ, Patel A, Ferrer MS, Ammon H, Mackinnon AC, Komorowski RA, Yan BC. Extracolonic gastrointestinal tract morphologic findings in a case of pseudomembranous collagenous colitis. Ann Diagn Pathol. 2013 Jun;17(3):291-4.
6. Bautista MC, Otterson MF, Zadvornova Y, Naik AS, Stein DJ, Venu N, Perera LP. Surgical outcomes in the elderly with inflammatory bowel disease are similar to those in the younger population. Dig Dis Sci. 2013 Oct;58(10):2955-62.
7. Perera LP, Ananthakrishnan AN, Guilday C, Remshak K, Zadvornova Y, Naik AS, Stein DJ, Massey BT. Dyssynergic defecation: a treatable cause of persistent symptoms when inflammatory bowel disease is in remission. Dig Dis Sci. 2013 Dec;58(12):3600-5.
8. Yarur AJ, Kanagala V, Stein DJ, Czul F, Quintero MA, Agrawal D, Patel A, Best K, Fox C, Idstein K, Abreu MT. Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease. Aliment Pharmacol Ther. 2017 Apr;45(7):933-940.
9. Westerouen van Meeteren MJ, Hayee B, Inderson A, van der Meulen AE, Altwegg R, van Hoek B, Pageaux GP, Stijnen T, Stein D, Maljaars PWJ. Safety of Anti-TNF Treatment in Liver Transplant Recipients: A Systematic Review and Meta-analysis. J Crohns Colitis. 2017 Sep 01;11(9):1146-1151.
10. Bhandari S, Larson ME, Kumar N, Stein D. Association of Inflammatory Bowel Disease (IBD) with Depressive Symptoms in the United States Population and Independent Predictors of Depressive Symptoms in an IBD Population: A NHANES Study. Gut Liver. 2017 Jul 15;11(4):512-519. PMCID: PMC5491086
11. Bhandari S, Mohammed Abdul MK, Dhakal B, Kreuziger LB, Saeian K, Stein D. Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients with Clostridium Difficile Infection. Inflamm Bowel Dis. 2017 Oct;23(10):1847-1852.
12. Stein DJ. Massage Acupuncture, Moxibustion, and Other Forms of Complementary and Alternative Medicine in Inflammatory Bowel Disease. Gastroenterol Clin North Am. 2017 Dec;46(4):875-880.
13. Bhandari S, Saeian K, Stein D. Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients With Clostridium difficile Infection. Inflamm Bowel Dis. 2018 Feb 15;24(3):661.
14. Niccum BA, Stein DJ, Behm BW, Hays RA. Zinc Deficiency and the Recurrence of <i>Clostridium difficile</i> Infection after Fecal Microbiota Transplant: A Retrospective Cohort Study. J Nutr Metab. 2018;2018:9682975. PMCID: PMC6199870
15. Beniwal-Patel P, Stein DJ, Munoz-Price LS. The Juncture Between Clostridioides difficile Infection and Inflammatory Bowel Diseases. Clin Infect Dis. 2019 Jul 02;69(2):366-372.
16. Ungaro RC, Yarur A, Jossen J, Phan BL, Chefitz E, Sehgal P, Kamal K, Bruss A, Beniwal-Patel P, Fox C, Patel A, Bahur B, Jain A, Stein D, Naik S, Dubinsky MC. Higher Trough Vedolizumab Concentrations During Maintenance Therapy are Associated With Corticosteroid-Free Remission in Inflammatory Bowel Disease. J Crohns Colitis. 2019 Aug 14;13(8):963-969. PMCID: PMC7185193
17. Mulgund A, Stein D. Is Biologic Therapy in Inflammatory Bowel Disease Contributing to the Obesity Epidemic? Just Weight One Year. Dig Dis Sci. 2020 Dec;65(12):3420-3421.
18. Stein DJ. All Systems Go: Reconsidering Healthcare Costs in Inflammatory Bowel Disease. Dig Dis Sci. 2021 Mar;66(3):660-661. PMCID: PMC7935728
19. Sekhri S, Rao B, Mohananey A, Beniwal-Patel P, Bruss A, Stein DJ, Yarur AJ. Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease. BMJ Open Gastroenterol. 2021 Nov;8(1). PMCID: PMC8587383
20. Johnson LK, Munoz-Price S, Patel PB, Patel A, Stein DJ, Yarur AJ. Outcomes in patients with inflammatory bowel disease and acute gastrointestinal symptoms who test indeterminate for Clostridioides difficile. Ann Gastroenterol. 2022 Mar-Apr;35(2):135-139. doi: 10.20524/aog.2022.0690. Epub 2022 Feb 14. PMID: 35479586; PMCID: PMC8922265.
21. Johnson LK, Munoz-Price S, Patel PB, Patel A, Stein DJ, Yarur AJ. Outcomes in patients with inflammatory bowel disease and acute gastrointestinal symptoms who test indeterminate for <i>Clostridioides difficile</i>. Ann Gastroenterol. 2022 Mar-Apr;35(2):135-139. PMCID: PMC8922265
22. Odufalu FD, Long M, Lin K, Mahadevan U, PIANO Investigators from the Crohn’s and Colitis Foundation (CCF) Clinical Research Alliance recruited patients for their respective centers for participant enrollment. Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry. Gut. 2022 Sep;71(9):1766-1772.
 
Books, Chapters, and Reviews
1. Gastrointestinal Emergencies Third Edition. 2015. "Complications of Upper Gastrointestinal Endoscopy" Daniel J. Stein MD and Reza Shaker MD
2. Stein, DJ. Inflammatory Bowel Disease: A Point of Care Clinical Guide. Can I stop my medications now that I am feeling well? Why maintenance therapy is important at preventing recurrence in Crohn's disease. Stein, DJ (eds) Springer Publishing 2015.91-98
3. Stein DJ. Inflammatory Bowel Disease: A Point of Care Clinical Guide. Was There Something I Did to Get Inflammatory Bowel Disease? Environmental and Dietary Factors That Contribute to IBD. Stein DJ, Kanagala V (eds) Springer Publishing 2015.7-14
4. Stein DJ. Inflammatory Bowel Disease: A Point of Care Clinical Guide. Why Can't I Continue to Take My Narcotics?: The Long Term Negative Effects of Narcotics. Rage A, Stein DJ (eds) Springer Publishing 2015.129-134
5. Stein DJ. Inflammatory Bowel Disease: A Point of Care Clinical Guide. Why Can’t I Just Stay on Prednisone? The Long-Term Adverse Effects of Steroids. Schiro A, Stein DJ (eds) Springer Publishing 2015.119-128
6. Stein DJ. Inflammatory Bowel Disease: A Point of Care Clinical Guide. What Happens If I Do Nothing for My Ulcerative Colitis? The Natural History of Untreated Ulcerative Colitis. Kanagala V, Stein DJ (eds) Springer Publishing 2015.41-51
7. Inflammatory Bowel Disease: A Point of Care Clinical Guide. Stein DJ and Shaker R editors. Springer Publishing. 2015
 
Abstracts
1. S Kugathasan, Daniel J. Stein, MT Rivera, B Seetharam, DG Binion,: Plasma Transcobalamin II (TC II) is elevated in children with established, but not newly diagnosed Crohn's disease (CD): Acquired alteration in microvascular expression. Gastroenterology, 116: A755, 1999.
2. DG Binion, KS Ramanujam, PJ Fisher, S Fu, MT Rivera, Daniel J. Stein, KT Wilson,: Loss of inducible nitric oxide synthase (iNOS) expression in inflammatory bowel disease (IBD) human intestinal microvascular endothelial cells (HIMEC) underlies leukocyte hyper adhesion.Gastroenterology, 116: A668, 1999.
3. MT Rivera, PJ Fisher, Daniel J. Stein, T Condon, J Tami, WE Shanahan, CF Bennett, DG Binion. Antisense oligonucleotides, but not steroids, inhibit human intestinal microvascular endothelial cell (HIMEC) adhesion molecule expression and leukocyte binding: A novel therapeutic strategy in intestinal inflammation. Gastroenterology, 116: A669, 1999.
4. P Rafiee, PJ Fisher, Daniel J. Stein, CP Johnson, DG Binion,: ICAM-1, but not VCAM-1 expression is blocked with tyrosine phosphorylation inhibitors in activated human intestinal microvascular endothelial cells (HIMEC): Potential role of ERK and p38 MAPK. Gastroenterology, 116: A920, 1999.
5. S Kugathasan, Daniel J. Stein, RL Truitt, DG Binion,: Distinct mucosal T cell phenotypes in early and late pediatric Crohn's disease (CD): Increased naïve T cells are found in late, but not early CD. Gastroenterology, 118: A347, 2000.
6. S Kugathasan, A Taras, Daniel J. Stein, PJ Fisher, TH Lamirand, RL Truitt, DG Binion,: Infliximab binds human monocytes, but not mucosal T cells in vitro: no direct anti-T cell mechanism of action. Gastroenterology, 118: A110, 2000.
7. Daniel J. Stein, P Rafiee, A Taras, TH Lamirand, PJ Fisher, H Ogawa, GL Telford, MF Otterson, CP Johnson, Binion DG,: Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC). Gastroenterology, 120: A278, 2001.
8. Daniel J. Stein, R Chiou, B Houghton, G Ochuba. "An Unusual Case of Abdominal Pain and Urethritis." 2003 American College of Physicians Annual Session. San Diego, CA. April 3-5.
9. Daniel J. Stein, W Diaz-Calderon, and GL Woods. "Fibrosing Cholestatic Hepatitis: A Rare Complication After Renal Transplant." American College of Physicians - Arizona Chapter Annual Meeting. Tucson, AZ. October 1-2, 2005.
10. Daniel J. Stein, HB El-Serag, J Kuczynski, JR Kramer, and RE Sampliner. "The Association of Barrett's Esophagus and Body Mass Index." American College of Gastroenterology 70th Annual Scientific Meeting. October 30 - November 2, 2005. Honolulu, Hawaii. A587
11. Daniel J. Stein, Mazen Issa, Sue Skaros, Josh F Knox, Kathryn Lemke, Jeanne Emmons, Mary F Otterson, Ashwin N Ananthakrishnan, David G Binion. "History of interrupted infliximab dosing significantly diminishes efficacy during long-term maintenance therapy in Crohn's Disease." Gastroenterology. 134(4), Suppl 1: A-666, 2008.
12. Stein DJ, Ananthakrishnan A, Ulitsky A, Naik AS, Marn C, Sudakoff G, Otterson MF, Perera LP, Binion DG, Issa M. Pre-operative small bowel follow through detects more strictures on a per stricture analysis than CT enterography when compared to intra-operative findings in patients with Crohn's disease. American College of Gastroenterology annual meeting, San Diego, October 2009.
13. Beaulieu DB, Ananthakrishnan AN, Zadvornova Y, Stein DJ, Mepani R, Antonik SJ, Skaros S, Johnson K, Naik AS, Perera LP, Binion DG. Does Duration of Disease Impact Health Related Quality of Life (HRQoL) in Inflammatory Bowel Disease? Digestive Disease Week, Chicago, June 2009
14. Beaulieu DB, Ashwin N Ananthakrishnan, Zadvornova Y, Stein DJ, Mepani R, Antonik SJ, Skaros S, Johnson K, Naik AS, Perera LP, Binion DG. Seasonal variation in HRQoL and disease activity in patients with inflammatory bowel disease: a tertiary care center experience. Gastroenterology 2009;136(Suppl 1): M1158.
15. Daniel J. Stein, Benson T. Massey, Thangam Venkatesan, Richard Komorowski and Walter J. Hogan. Chronic Idiopathic Enterocolitis (CIE): Maintaining a Corticosteroid Free Response with Immunosuppressive Therapy. Digestive Disease Week, New Orleans, May 2010.
16. Zadvornova Y, Ashwin N Ananthakrishnan, Stein DJ, Skaros S, Johnson K, Naik AS, Perera LP, Issa M. Infliximab monotherapy vs. combined infliximab-immunomodulator therapy in ulcerative colitis. Digestive Disease Week, New Orleans, May 2010.
17. Kwiatt, James T., Stein, Daniel J., Naik, Amar S., Ananthakrishnan, Ashwin N., Perera, Lilani P. The 2009 Influenza Pandemic: Seasonal and H1N1 Influenza Vaccination Rates are Increasing in an IBD Population in 2009. Digestive Disease Week, New Orleans, May 2010.
18. Naik AS, Zadvornova Y, Issa M, Skaros S, Ward S, Ward A, Johnson K, Tyler K, Stein DJ, Perera LP, Ashwin N Ananthakrishnan. Tubular adenoma and low grade dysplasia in inflammatory bowel disease: Who is at risk? Digestive Disease Week, New Orleans, May 2010.
19. Selamawit Tarekegn, Kristin Oimoen, Yelena Zadvornova, Daniel Eastwood, Mazen Issa, Amar S. Naik, Daniel J. Stein, Nanda Venu, Lilani P. Perera Biologics Are Superior to Immunomodulators in Prevention of Post-Operative Recurrence of Crohn's Disease Digestive Disease Week 2011 Chicago, IL Mo1243 -- 2011
20. Adeeti Chiplunker, Yelena Zadvornova, Mazen Issa, Daniel J. Stein, Lilani P. Perera, Nanda Venu, Amar S. Naik Factors Associated with Repeat Hospitalizations in Inflammatory Bowel Disease Digestive Disease Week 2011 Chicago, IL. Tu1264 -- 2011
21. Amar S. Naik, Yelena Zadvornova, Sarah J. Lundeen, Daniel J. Stein, Nanda Venu, Mary F. Otterson, Mazen Issa, Lilani P. Perera Abdominal Venous Thrombosis Following Inflammatory Bowel Disease Related Surgeries While On Dalteparin Prophylaxis. Digestive Disease Week 2011 Chicago, IL Su1213 -- 2011
22. Mazen Issa, Yelena Zadvornova, Amar S. Naik, Daniel J. Stein, Nanda Venu, Lilani P. Perera High Rates of Escalation and Termination of Adalimumab Therapy and Patients Exposed to Infliximab . Digestive Disease Week 2011 Chicago, IL : Mo1226 -- 2011 AGA Poster of Distinction
23. Mazen Issa, Yelena Zadvornova, Daniel J. Stein, Nanda Venu, Lilani P. Perera1, David G. Binion, Amar S. Naik Long-Term Use of Purine Analogues in Inflammatory Bowel Disease: A Single Referral Center Experience Digestive Disease Week 2011 Chicago, IL Tu1293 -- 2011
24. Roy Liu, Kristin Oimoen, Yelena Zadvornova, Jessica Pruszynski, Amar S. Naik, Daniel J. Stein, Nanda Venu, Lilani P. Perera Advanced Age At Diagnosis Does Not Negatively Impact Health Related Quality of Life in IBD: Performance of SIBDQ in a Longterm Cohort Study: Digestive Disease Week 2011 Chicago, IL Tu1312 -- 2011
25. Agnes Libot, Mazen Issa, Yelena Zadvornova, Daniel J. Stein, Nanda Venu, Lilani P. Perera, Amar S. Naik Initial Vancomycin Monotherapy Is Associated with Higher Rates of Subsequent Clostridium Difficile Infection in Inflammatory Bowel Disease Population Digestive Disease Week 2011 Chicago, IL Oral Presentation
26. Perera LP, Zadvornova Y, Binion DG, Guilday C, Stein DJ, Naik AS, Venu N, Best K, Skaros S. Long term outcomes of crohn’s disease patients on maintenance anti-TNF-α therapy. Presented as a poster at Digestive Disease Week 2012.
27. Perera LP, Zadvornova Y, Massey BT, Guilday C, Stein DJ, Naik AS, Best K, Skaros S. Increased rate of non-melanoma skin cancer detection with screening skin exam in inflammatory bowel disease: Is it time to recommend routine dermatology care? Presented as a poster at Digestive Disease Week 2012.
28. Perera LP, Zadvornova Y, Saeian K, Guilday C, Stein DJ, Naik AS, Venu N, Best K, Skaros S. Durability of Anti TNF α therapy in Ulcerative Colitis: Switching is an Effective Strategy in a Small Subset of patients. Presented as a poster at Digestive Disease Week 2012.
29. Perera LP, Zadvornova Y, Binion D, Guilday C, Stein DJ, Naik AS, Venu N, Best K, Skaros S. 10 year performance of anti TNF biologic therapy in inflammatory bowel disease. Digestive Disease Week 2012. San Diego, CA
30. Desai P, Sharma A, Naik AS, Otterson M, Zadvornova Y, Perera L, Venu N, Stein DJ. Timing of Pre-Operative Anti-Tumor Necrosis Factor Therapy Does Not Affect Early Post-Operative Complication Rates in Inflammatory Bowel Disease Patients Undergoing Intestinal Resection. DDW 2012
31. Stein DJ, Zadvornova Y, Lin E, Naik AS, Perera LP, Venu N, Otterson MF, Binion DG. Long-Term Clinical Outcomes Following Surgery in Crohn's Disease Patients on Combination Immunosuppression: Impact of Anastomotic Reconstruction on Quality of Life and Healthcare Utilization. Digestive Disease Week 2013 Orlando, FL
32. Venu M, Dodda A, Gonzaga JE, Naik AS, Venu N, Perera LP, Stein DJ. Outcomes in IBD Patients WHO Are Exposed to a Subsequent Anti-TNF Agent Following Anti-TNF Drug Induced Lupus-Like Reaction. Digestive Disease Week 2013 Orlando, FL
33. Radigan M, Guilday C, Visotcky A, Massey BT, Stein DJ, Naik AS, Venu N, Best K, Skaros S, Perera LP. Development of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease: Significant Association With Presence of Psychiatric Illness and Early Onset IBD. Digestive Disease Week 2013 Orlando, FL.
34. Guilday C, Eastwood D, Zadvornova Y, Stein DJ, Naik AS, Best K, Skaros S, Perera LP. Concomitant Use of Immunomodulator Therapy Results in Higher Serum Infliximab Levels Compared to Monotherapy Without Lowering Serum Haca Levels. Digestive Disease Week 2013 Orlando, FL.
35. Aadam AA, Saeian K, Massey BT, Stein DJ, Ashley L, Venu N, Venu M, Oh Y. Proximal Colon Retroflexion With Adult Versus Pediatric Colonoscopies. Digestive Disease Week 2013 Orlando, FL.
36. Ashir Z, Guilday C, Zadvornova Y, Stein DJ, Naik AS, Venu N, Best K, Skaros S, Saeian K, Perera LP. Mucosal Healing by Individual Anti TNF Agent in Crohn's Disease in Tertiary Care Setting. Digestive Disease Week 2013 Orlando, FL.
37. Naik AS, Zadvornova Y, Stein DJ, Shastri N, Venu M, Best K, Perera LP, Saeian K, Venu N. Factors Associated With 30 Day Re-Admission in Inflammatory Bowel Disease. Digestive Disease Week 2013 Orlando, FL.
38. Stein DJ, Zadvornova Y, Lin E, Naik AS, Perera LP, Venu N, Otterson MF, Binion DG. , Long-Term Clinical Outcomes Following Surgery in Crohn's Disease Patients on Combination Immunosuppression: Impact of Anastomotic Reconstruction on Quality of Life and Healthcare Utilization, Digestive Disease Week 2013, Orlando, FL, 5/18/2013 - 5/21/2013
39. Patel A, Zadvornova Y, Stein DJ, Naik AS, Best K, Idstein K, Massey BT, Perera LP. Anti TNF therapy in Inflammatory Bowel Disease: predictors of weight gain and development of obesity. Digestive Disease Week 2014. Chicago, IL.
40. Kanagala V, Zadvornova Y, Naik AS, Perera LP, Stein DJ. Asymptomatic Inflammatory Bowel Disease Patients with an Elevated CRP Are At Increased Risk of Hospitalization and Surgery Within Two Years of Follow up. Digestive Disease Week 2014. Chicago, IL.
41. Naik AS, Zadvornova Y, Stein DJ, Perera LP, Saeian K, Venu N. Impact of BMI on Inflammatory Bowel Disease Patients Diagnosed in Adolescence. Digestive Disease Week 2014. Chicago, IL.
42. Naik AS, Zadvornova Y, Stein DJ, Agrawal D, Venu N, Saeian K, Impact of Adenomatous Colon Polyps on Inflammatory Bowel Disease (IBD) CRC Surveillance., Digestive Disease Week 2015, Washington DC, 5/16/2015 - 5/19/2015
43. Stein DJ, Ansari I, Cahill J, Agrawal D, Naik AS, Zadvornova Y. The Majority of Inflammatory Bowel Disease Patients Feel That an Elimination Diet Trial Had Resulted in Disease Symptom Improvement. Digestive Disease Week 2015, Washington DC, 5/16/2015 - 5/19/2015
44. Modiri A, Naik AS, Rizvi S, Zadvornova Y, Stein DJ. Inflammatory Bowel Disease Patients With Solid Organ Transplants Who Require Anti-TNF Therapy Are Not at Increased Risk of Serious Infections. Digestive Disease Week 2015, Washington DC, 5/16/2015 - 5/19/2015
45. Cahill J, Zadvornova Y, Naik AS, Agrawal D, Best K, Stein DJ, Azothioprine or 6-Mercaptopurnine Dose Does Not Effect Serum Infliximab Level or Rate of Antibody to Infliximab Formation, Digestive Disease Week 2015, Washington DC, 5/16/2015 - 5/19/2015
46. Stein DJ, Rizvi S, Modiri A, Fang T, Naik AS. Two Case Reports of Toxic Megacolon From Clostridium difficile Infection Successfully Treated With Fecal Microbiota Therapy, Digestive Disease Week 2015, Washington DC, 5/16/2015 - 5/19/2015
47. A Yarur, V Kanagala, DJ Stein, F Czul, D Agrawal, Y Zadvornova, MA Quintero, MT Abreu. Higher Infliximab Trough Levels Are Associated With a Higher Rate of Perianal Fistula Healing in Patients With Crohn's Disease. Poster presentation at Digestive Disease Week. San Diego, CA. May 2016
48. Nichole Sly, PharmD, Shannon Werner, PharmD, Renee Pitt, PharmD, Ruta Bajorunaite, ScM, Lisa Rein, PhD, Daniel Stein, MD. Accelerated Dosing of Infliximab Is Not Associated With Improved Colectomy Rates in Hospitalized Severe Ulcerative Colitis Patients. World Congress of Gastroenterology at ACG2017 meeting in Orlando, FL. October 2017.
49. H Bader, AN Modiri, Y Zadvornova, DJ Stein. Mucosal Healing Rates in Patients with Upper Gastrointestinal Tract Crohn’s Disease. Poster Presentation. Digestive Disease Week, Chicago, IL, May 2017.
50. AJ Yarur, A Bruss, A Jain, V Kondragunta, TL Luna, K Hester, A Patel, D Agrawal, C Fox, S Werner, S Naik, DJ Stein. Higher Vedolizumab Levels are Associated with Deep Remission in Patients with Crohn's Disease and Ulcerative Colitis on Maintenance Therapy with Vedolizumab. Poster Presentation. Digestive Disease Week, Chicago, IL, May 2017.
51. AJ Yarur, A Bruss, B Berens, C Fox, PM Beniwal-Patel, A Patel, RC Ungaro, M Dubinsky, S Naik, DJ Stein. VEDOLIZUMAB LEVELS DURING INDUCTION ARE ASSOCIATED WITH LONG-TERM CLINICAL AND ENDOSCOPIC REMISSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Poster Presentation. Digestive Disease Week 2018
52. Yarur AJ, Atkinson SN, Haque J, Beniwal-Patel PM, Stein DJ, Munoz-Price S. Differences In The Fecal Microbiome And Metabolome Of Patients With Acute Diarrhea Tested for Clostridioides Difficile Infection. Presented at DDW 2020 (Virtual Conference)
53. Nguyen BCH, Mulgund A, Beniwal-Patel PM, Patel A, Stein DJ, Yarur AJ. Endoscopic Assessment in Acute Severe Ulcerative Colitis is Safe and Associated with Short-term but not Long-term Outcomes. Poster Presentation. Digestive Disease Week 2020
54. Schwartz M, Stein DJ, Patel A, Beniwal-Patel PM, Otterson MF, Yarur AJ. Prevalence and Clinical Significance of Anastomotic Ring Inflammation After Ileal Resection and Ileo-Colonic Anastomosis in Patients With Crohn's Disease. Virtual Presentation at Digestive Disease Week 2020
55. Johnson L, Ghufran A, Beniwal-Patel P, Stein DJ. Future GI Fellowship Applicants to Gastroenterology fellowships more likely to be female despite perception of gender bias but underrepresented minority applicant disparities persist in setting of ongoing racial bias. ePoster Presentation for DDW Virtual 2021.
56. Stein, Daniel J. NEW AGENTS FOR IBD: BIOSIMILARS FOR ALL? 2021 Chat (DDW Virtual Presentation)
57. Yarur AJ, Bruss A, Nunez L, Moosreiner A, Stein DJ, Agrawal D, and others. Higher Visceral Adipose Tissue Is Associated With Lower Rates Of Steroid-Free Deep And ---Endoscopic Remission In Patients Starting Biologic Therapy For Inflammatory Bowel Diseases: Results From The Constellation Study. Gastroenterology. 2021 May;160 (6):S-79.
58. Mulgund, Aditi, Yarur, Andres, Stein, Daniel, Beniwal-Patel, Poonam: The implementation of a pilot study of a standardized inflammatory bowel disease curriculum for gastroenterology fellows. Crohn’s and Colitis Congress. January 2021. Virtual format.
59. Boscheutz N, Ghufran A, Stein D, Beniwal-Patel P. Male and Female fellows have similar motivators behind career planning. Presented as Poster Presentation, DDW 2021, virtual.
60. Hipp, L., Esteban, JP, Stein, D., Yarur, A., Beniwal-Patel, P. No Association Between Non-alcoholic Steatohepatitis or Advanced Fibrosis and IBD Clinical Remission at One and Five Years. Presented as Poster Presentation, DDW 2021, virtual.
61. Daniel Stein: Biologics and jak inhibitors decrease major cardiovascular events (mace) in IBD patients. Data from a large National cohort. Is it the mechanism of the drug or control of disease?. Presented as Poster Presentation, on May 20th, 2024, during the Research Forum component of the Annual DDW meeting in Washington, D.C.